KEGG   DRUG: Somapacitan
Entry
D11194                      Drug                                   

Name
Somapacitan (USAN/INN);
Somapacitan (genetical recombination) (JAN);
Somapacitan-beco;
Sogroya (TN)
Formula
C1038H1609N273O319S9
Exact mass
23290.5561
Mol weight
23305.1048
Sequence
FPTIPLSRLF DNAMLRAHRL HQLAFDTYQE FEEAYIPKEQ KYSFLQNPQT SLCFSESIPT
PSNREETQQK SNLELLRISL LLIQSWLEPV QFLRSVFANS CVYGASDSNV YDLLKDLEEG
IQTLMGRLED GSPRTGQIFK QTYSKFDTNS HNDDALLKNY GLLYCFRKDM DKVETFLRIV
QCRSVEGSCG F
(Disulfide bridge: 53-165, 182-189)
  Type
Peptide
Efficacy
Growth hormone (GH) receptor agonist
  Disease
Growth hormone deficiency [DS:H00254]
Comment
Treatment of growth hormone dificiency
albumin-binding growth hormone
Target
GHR [HSA:2690] [KO:K05080]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04080  Neuroactive ligand-receptor interaction
hsa04151  PI3K-Akt signaling pathway
hsa04630  JAK-STAT signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    GHR
     D11194  Somapacitan (USAN/INN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11194
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11194
Other DBs
CAS: 1338578-34-9
PubChem: 384585173
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system